The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis.
Open accessAbstract
Interferon, induced in lymphocytes either with viruses or cell lines, increases severalfold the natural cytotoxicity of human lymphocytes on target cell lines. Cell separation experiments support the hypothesis that interferon enhances the activity of natural killer cells rather than generating a new population of effector cells. In mixed culture of lymphocytes and cell lines in which endogenous interferon is produced, interferon mediates an enhancement of cytotoxicity that represents up to 70-90% of the observed cytotoxicity. The effect of interferon on target cells is antagonistic to the effect on the lymphocytes: the susceptibility to cell-mediated lysis of various cells upon pretreatment with interferon is decreased and in some cases almost completely suppressed. Interferon renders target cells resistant to natural killer cells acting by an intracellular mechanism which requires RNA and protein synthesis. While normal fibroblasts are protected, virus-infected cells and most tumor cells usually are not protected by interferon. Interferon by stimulating very efficient nonspecific cytotoxic cells and by protecting at the same time normal cells from lysis, might render the natural killer cell system an inducible selective defense mechanism against tumor and virus-infected cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A rapid method for the isolation of functional thymus‐derived murine lymphocytes
Julius, M. H., Simpson, E., & Herzenberg, L. A. (1973) · European Journal of Immunology · doi:10.1002/eji.1830031011 · Cited by 4,147
Virus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
Kiessling, R., Klein, E., & Wigzell, H. (1975) · European Journal of Immunology · doi:10.1002/eji.1830050208 · Cited by 1,824
Herberman, R. B., Nunn, M. E., & Lavrin, D. H. (1975) · International Journal of Cancer · doi:10.1002/ijc.2910160204 · Cited by 1,355
Reactivity of lymphocytes from normal persons on cultured tumor cells.
Takasugi, M., Mickey, M. R., & Terasaki, P. I. (1973) · PubMed · Cited by 433
Kay, H. D., Bonnard, G. D., West, W. H., & Herberman, R. B. (1977) · The Journal of Immunology · doi:10.4049/jimmunol.118.6.2058 · Cited by 343
Jondal, M., & Pross, H. F. (1975) · International Journal of Cancer · doi:10.1002/ijc.2910150409 · Cited by 335
Influenza virus structural and nonstructural proteins in infected cells and their plasma membranes
Lazarowitz, S. G., Compans, R. W., & Choppin, P. W. (1971) · Virology · doi:10.1016/0042-6822(71)90084-5 · Cited by 316
Herberman, R. B., Nunn, M. E., Holden, H. T., Staal, S., & Djeu, J. Y. (1977) · International Journal of Cancer · doi:10.1002/ijc.2910190417 · Cited by 301
Trinchieri, G., Santoli, D., Dee, R. R., & Knowles, B. B. (1978) · The Journal of experimental medicine · doi:10.1084/jem.147.5.1299 · Cited by 299
Self-citation
Cited by
Biology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902
Self-citationIn search of the ‘missing self’: MHC molecules and NK cell recognition
Ljunggren, H.-G., & Kärre, K. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90097-s · Cited by 2,687
Kobayashi, M., Fitz, L., Ryan, M., Hewick, R. M., Clark, S. C., Chan, S., Loudon, R., Sherman, F., Perussia, B., & Trinchieri, G. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.3.827 · Cited by 1,953
Self-citationZinkernagel, R. M., & Doherty, P. C. (1979) · Advances in Immunology · doi:10.1016/s0065-2776(08)60262-x · Cited by 1,933
Severe Herpesvirus Infections in an Adolescent without Natural Killer Cells
Biron, C. A., Byron, K. S., & Sullivan, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906293202605 · Cited by 1,269
Prospects for combining targeted and conventional cancer therapy with immunotherapy
Gotwals, P., Cameron, S., Cipolletta, D., Cremasco, V., Crystal, A., Hewes, B., Mueller, B., Quaratino, S., Sabatos-Peyton, C., Petruzzelli, L., et al. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.17 · Cited by 953
Immune Interferon in the Circulation of Patients with Autoimmune Disease
Hooks, J. J., Moutsopoulos, H. M., Geis, S. A., Stahl, N. I., Decker, J. L., & Notkins, A. L. (1979) · New England Journal of Medicine · doi:10.1056/nejm197907053010102 · Cited by 921
Type I interferon: friend or foe?
Trinchieri, G. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20101664 · Cited by 844
Self-citationNatural Killer Cells: Characteristics and Regulation of Activity
Herberman, R. B., Djeu, J. Y., Kay, H. D., Ortaldo, J. R., Riccardi, C., Bonnard, G. D., Holden, H. T., Fagnani, R., Santoni, A., & Puccetti, P. (1979) · Immunological Reviews · doi:10.1111/j.1600-065x.1979.tb00267.x · Cited by 575
Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity
HERBERMAN, R. R., ORTALDO, J. R., & BONNARD, G. D. (1979) · Nature · doi:10.1038/277221a0 · Cited by 522
Direct Effects of Type I Interferons on Cells of the Immune System
Hervas-Stubbs, S., Perez-Gracia, J. L., Rouzaut, A., Sanmamed, M. F., Le Bon, A., & Melero, I. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1114 · Cited by 503
The interferons and their receptors—distribution and regulation
de Weerd, N. A., & Nguyen, T. (2012) · Immunology & Cell Biology · doi:10.1038/icb.2012.9 · Cited by 480
STING Agonists as Cancer Therapeutics
Amouzegar, A., Chelvanambi, M., Filderman, J., Storkus, W., & Luke, J. (2021) · Cancers · doi:10.3390/cancers13112695 · Cited by 395
Gerosa, F., Gobbi, A., Zorzi, P., Burg, S., Briere, F., Carra, G., & Trinchieri, G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.727 · Cited by 393
Self-citationPreferential effect of γ interferon on the synthesis of HLA antigens and their mRNAs in human cells
Wallach, D., Fellous, M., & Revel, M. (1982) · Nature · doi:10.1038/299833a0 · Cited by 383
Serum interferon levels in patients with systemic lupus erythematosus
Ytterberg, S. R., & Schnitzer, T. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780250407 · Cited by 382
The Yin and Yang of Toll-like receptors in cancer
Pradere, J.-P., Dapito, D. H., & Schwabe, R. F. (2014) · Oncogene · doi:10.1038/onc.2013.302 · Cited by 331
NK Cells, MHC Class I Molecules and the Missing Self
Kärre, K. (2002) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2002.01053.x · Cited by 325
Trinchieri, G., Santoli, D., Dee, R. R., & Knowles, B. B. (1978) · The Journal of experimental medicine · doi:10.1084/jem.147.5.1299 · Cited by 299
Self-citationPathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice
Bukowski, J. F., Woda, B. A., & Welsh, R. M. (1984) · Journal of Virology · doi:10.1128/jvi.52.1.119-128.1984 · Cited by 282
Reduced Natural Killer Cell Activity in Autism
WARREN, R. P., FOSTER, A., & MARGARETTEN, N. C. (1987) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198705000-00008 · Cited by 190
Metadata
- Authors
- Trinchieri, G., & Santoli, D.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1978-05-01
- Volume
- 147
- Issue
- 5
- Pages
- 1314-1333
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2143143209
- Cited by
- 733
- References
- 23
- FWCI
- 30.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.